Stanley Fisher, M.D.
Co-Director of Movement Disorders & Neuro-rehabilitation Center
Methodist Neurological Institute
Associate Professor of Clinical Neurology
Weill Cornell Medical College
6560 Fannin Street, Suite 802
Houston, TX 77030
Dr. Stanley Fisher has been with the Methodist Neurological Institute (NI) for more than seven years. He is currently a Co-Director of Movement Disorders and Neuro-rehabilitation Center and Associate Professor of Clinical Neurology at Weill Medical College, Cornell University. He joined the NI from the University of Texas – Houston where he also completed his Neurology Residency and Fellowship in Movement Disorders.
Dr. Fisher was a robotic engineer before returning to Temple University, where he graduated Cumma Sum Laude with a BA in Biology and Cognitive Neuroscience. During his college years Dr. Fisher was a well-known Personal and Fitness trainer in Philadelphia.
After his residency, Dr. Fisher combined his skills as a robotic engineer, fitness trainer and neurologist to do research in the use of robotically-assisted technology for neurological rehabilitation. He became an internationally recognized expert in the field of Neuromodulation, utilizing implantable devices for the treatment of Parkinson’s disease, tremors, dystonia as well as spasticity due to stroke, multiple sclerosis, traumatic brain and spinal cord injury.
Dr. Fisher collaborates extensively with the researchers and engineers at the Center for Neuromotor and Biomechanics Research and joined the faculty of the Department of Health and Human Performance at the University of Houston.
Dr. Fisher is invited to lecture nationally and internationally on the use of implantable and robotically-assisted devices for the treatment of the wide variety of neurological diseases.
- Movement disorders including tremor, dystonia, chorea and myoclonus.
- Parkinson’s disease, Alzheimer’s Disease, Huntington’s disease and other neurodegenerative disorders.
- Gait Disorders and Normal Pressure Hydrocephalus.
- Deep Brain Stimulation for Parkinson’s disease, Tremors of different etiology and Generalized dystonia.
- Chemodenervation with Botulinum Toxins for Focal Dystonias, Spasticity, Headaches, and muscle spasms.
- Comprehensive Neurorehabilitation, utilizing advanced robotically-assisted technology, chemodenervation, and Intrathecal Baclofen Pump Therapy to optimize the recovery from neurological catastrophes.
- Motor recovery utilizing Autoambulator and other robotically assisted technology
- Use of Intrathecal Baclofen Pump therapy for spastic hemiplegia in patients with stroke
- Use of Virtual Reality and Functional Electrical Stimulation in the process of neurological recovery
- Neuroprotection in stroke, Parkinson’s disease and other neurodegenerative disorder
- Parkinson’s Disease Psychosis
- Neurogenic Orthostatic Hypotension
- Use of Botulinum toxins for the treatment of focal dystonias and spasticity
- Novel therapeutic agents for Alzheimer’s dementia
M.D. - Hahnemann University
Neurology Residency - University of Texas -Houston
Movement Disorders Fellowship - University of Texas-Houston
American Board of Psychiatry & Neurology
- Mya Schiess, MD, Irene Oh, MD, Erin F. Stimming, MD, Joseph Lucke, PhD, Fernando Acosta, MD, Stanley Fisher, MD, Richard Simpson, MD, PHD. Prospective 12-Month Study of Intrathecal Baclofen for Poststroke Spastic Upper and Lower Extremity Motor Control and Functional Improvement. Neuromodulation: Technology at the Neural Interface 2011;14:38-45.
- Thrasher TA, Ward JS, Fisher S. Classification of rhythmic locomotor patterns in electromyographic signals using fuzzy sets. Journal of Neuroengineering and Rehabilitation, November 2011.
- Fisher S, Lucas l, Thrasher A. Robot-assisted gait training for patients with hemiparesis due to stroke. Topics in stroke rehabilitation.Top Stroke Rehabil. 2011 May-Jun;18(3):269-76.